Transplantation, Autologous
"Transplantation, Autologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of an individual's own tissue from one site to another site.
| Descriptor ID |
D014182
|
| MeSH Number(s) |
E04.936.664
|
| Concept/Terms |
Transplantation, Autologous- Transplantation, Autologous
- Autotransplantation
- Autotransplantations
- Autografting
- Autograftings
- Autologous Transplantation
- Autologous Transplantations
- Transplantations, Autologous
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Autologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Autologous".
This graph shows the total number of publications written about "Transplantation, Autologous" by people in this website by year, and whether "Transplantation, Autologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 2 | 2 |
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 6 | 6 |
| 1999 | 2 | 7 | 9 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 7 | 7 |
| 2002 | 2 | 6 | 8 |
| 2003 | 0 | 10 | 10 |
| 2004 | 0 | 6 | 6 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 8 | 9 |
| 2007 | 0 | 4 | 4 |
| 2008 | 1 | 10 | 11 |
| 2009 | 2 | 6 | 8 |
| 2010 | 0 | 5 | 5 |
| 2011 | 0 | 7 | 7 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 10 | 10 |
| 2014 | 3 | 4 | 7 |
| 2015 | 0 | 9 | 9 |
| 2016 | 0 | 3 | 3 |
| 2017 | 1 | 8 | 9 |
| 2018 | 0 | 10 | 10 |
| 2019 | 2 | 6 | 8 |
| 2020 | 0 | 9 | 9 |
| 2021 | 2 | 25 | 27 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Autologous" by people in Profiles.
-
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023 02; 24(2):139-150.
-
Commentary on: Supplementation of Facial Fat Grafting to Increase Volume Retention: A Systematic Review. Aesthet Surg J. 2022 12 14; 42(12):NP728-NP729.
-
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials. Transplant Cell Ther. 2023 Mar; 29(3):174.e1-174.e10.
-
A Prospective, Randomized Comparison of Clinical Outcomes with Different Processing Techniques in Autologous Fat Grafting. Plast Reconstr Surg. 2022 11 01; 150(5):955-962.
-
Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 11; 22(11):e1000-e1008.
-
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. Haematologica. 2022 07 01; 107(7):1608-1618.
-
Spleen-preserving total pancreatectomy and islet autotransplantation with complete preservation of the splenic arterial and venous supply does not impact islet yield and function. Am J Surg. 2022 11; 224(5):1295-1300.
-
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
-
Response to: Additional Thoughts on the Future of Fat Grafting. Aesthet Surg J. 2022 01 01; 42(1):NP85-NP86.
-
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma. N Engl J Med. 2022 02 17; 386(7):640-654.